List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 884 studies with search of:   United States, Delaware
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Active, not recruiting Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma
Conditions: Leukemia;   Lymphoma
Interventions: Drug: cyclophosphamide;   Drug: filgrastim;   Drug: fludarabine phosphate;   Drug: therapeutic allogeneic lymphocytes;   Procedure: peripheral blood stem cell transplantation
22 Active, not recruiting Bortezomib and Liposomal Doxorubicin in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: pegylated liposomal doxorubicin hydrochloride
23 Active, not recruiting Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: bicalutamide;   Drug: flutamide;   Drug: goserelin;   Drug: iodine I 125;   Drug: leuprolide acetate;   Drug: palladium Pd 103;   Procedure: brachytherapy;   Procedure: neoadjuvant therapy;   Procedure: radiation therapy
24 Active, not recruiting Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: aldesleukin;   Drug: busulfan;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: filgrastim;   Procedure: peripheral blood stem cell transplantation
25 Recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: letrozole;   Drug: placebo
26 Recruiting Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer
Interventions: Drug: bevacizumab;   Drug: cisplatin;   Drug: docetaxel;   Drug: fluorouracil
27 Recruiting Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
Condition: Colorectal Cancer
Interventions: Drug: cetuximab;   Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: oxaliplatin
28 Active, not recruiting Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: carboplatin;   Drug: ixabepilone;   Drug: trastuzumab
29 Active, not recruiting Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: epirubicin hydrochloride;   Drug: fluorouracil
30 Active, not recruiting Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
Condition: Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: capecitabine;   Drug: gemcitabine hydrochloride;   Procedure: radiation therapy
31 Recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: exemestane;   Drug: letrozole;   Drug: tamoxifen citrate;   Procedure: chemotherapy
32 Recruiting GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (NSAIDS)
Condition: Osteoarthritis
Interventions: Drug: Celecoxib;   Drug: Any commercially available NSAID with the indication for osteoarthritis
33 Active, not recruiting Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: ABVD regimen;   Drug: Stanford V regimen;   Drug: bleomycin;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mechlorethamine hydrochloride;   Drug: prednisone;   Drug: vinblastine;   Drug: vincristine sulfate;   Procedure: radiation therapy
34 Recruiting Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: exemestane;   Drug: tamoxifen citrate;   Drug: triptorelin;   Procedure: adjuvant therapy;   Procedure: oophorectomy;   Procedure: radiation therapy
35 Active, not recruiting Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Drug: bevacizumab;   Drug: gemcitabine hydrochloride
36 Completed Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
Condition: Anal Cancer
Interventions: Drug: cisplatin;   Drug: fluorouracil;   Drug: mitomycin C;   Procedure: radiation therapy
37 Active, not recruiting Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
Conditions: Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: anti-thymocyte globulin;   Drug: busulfan;   Drug: filgrastim;   Drug: fludarabine phosphate;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Drug: tacrolimus;   Drug: therapeutic allogeneic lymphocytes;   Procedure: allogeneic bone marrow transplantation;   Procedure: graft-versus-tumor induction therapy;   Procedure: peripheral blood stem cell transplantation
38 Recruiting Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive Candidiasis
Conditions: Candidiasis;   Candida
Intervention: Drug: anidulafungin
39 Active, not recruiting Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
Condition: Breast Cancer
Interventions: Drug: anastrozole;   Drug: tamoxifen citrate;   Procedure: adjuvant therapy;   Procedure: radiation therapy
40 Recruiting Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery
Condition: Kidney Cancer
Interventions: Drug: placebo;   Drug: sorafenib tosylate;   Drug: sunitinib malate

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services